the risk factors, and assess host cellular immunity against fungal infections through interleukin 17 (IL-17).
Patients and methods

Study design
This was a prospective study carried out at Assiut University Hospital (AUH), Egypt, from January to August 2013. The study was approved by the ethics committee of AUH. Patients (or relatives of comatose patients) provided informed consent for study participation. The aim of the present study was to demonstrate the frequency of IFI in ESLD, risk factors, and cellular immunity against it.
Patients
Forty-six patients with ESLD were selected from the intensive care unit (ICU) of the Tropical Medicine and Gastroenterology Department, AUH. All patients met the diagnostic criteria for liver cirrhosis by clinical, biochemical, and ultrasonography findings. The severity of liver cirrhosis was assessed according to the Child-Pugh classification and model for end-stage liver disease (MELD) score. 6, 7 Cirrhotic patients with a history of intra-abdominal surgery were not included in the study to exclude secondary peritonitis.
At study entry, a thorough medical history was taken and physical examination performed, and blood and ascitic fluid samples were collected. In-hospital mortality was assessed.
Specimen collection and processing
For each patient, 15-20 ml of blood and ascitic fluid were collected aseptically. Three milliliters of the blood sample were used for serum separation and stored at À20 8C (for assessment of IL-17, serology for HIV and cytomegalovirus (CMV), and also for DNA extraction). The remaining sample was used for biochemical examination, complete blood picture, and microbiological culture. Two milliliters of the ascitic fluid sample were stored at À20 8C (for DNA extraction for the detection of universal fungal gene), while the remaining sample was used for smears, bacterial and fungal cultures, and biochemical examination.
Specimen examination
Liver function, kidney function, blood picture (total and differential white blood cell count), and serum glucose and sodium were determined using the blood samples. The total leukocyte count, cell types, total protein content, and cytology were assessed in the ascitic fluid samples.
Assessment of the IL-17 level in serum was done by ELISA (Quantikine ELISA, Human IL-17; R&D Systems) as per the manufacturer's instructions.
HIV serology was determined by simultaneous qualitative detection of HIV p24 antigen and antibodies to HIV type 1 and/or type 2 (Abbott ARCHITECT HIV Ag/Ab Combo Assay). In addition, CMV antibodies were detected using the Abbott ARCHITECT CMV IgM and IgG assays in accordance with the manufacturer's instructions.
Smears were made from centrifuged ascitic fluid samples and were stained with Gram stain, Ziehl-Neelsen stain, and India ink stain (for the detection of Cryptococcus neoformans capsules if present).
For cultures, each ascitic fluid and blood sample was inoculated in an aerobic blood culture bottle (for detection of aerobic bacteria), in two bottles of Sabouraud's dextrose broth (for fungal detection), and on Lowenstein-Jensen (LJ) slants (for Mycobacterium detection). Aerobic blood culture bottles were incubated at 37 8C, while Sabouraud's dextrose broth bottles were incubated at 25 8C and 37 8C, respectively, for up to 14 days, or until positive growth was detected. Candida colonies on Sabouraud's dextrose agar were identified by Gram stain, germ tube test, and culture on CHROMagar Candida medium (CHROMagar, Paris, France) and corn meal agar. Filamentous fungi on Sabouraud's dextrose agar were identified macroscopically and microscopically by examining the shape and arrangement of the conidia using lactophenol cotton blue stain. 8 For bacterial cultures, subcultures were done on blood agar and MacConkey agar. The LJ slants were incubated at 37 8C for 4-8 weeks and observed weekly.
DNA extraction from serum and ascitic samples
For serum samples, DNA was extracted using the QIAamp DNA Blood Mini Kit (Qiagen, Germany), while for ascitic fluid samples, DNA was extracted using the MasterPure Complete DNA Purification Kit (Epicenter Biotechnologies, Madison, WI, USA), both in accordance with the manufacturer's instructions.
Primers for fungal detection
Universal fungal primers for 28S rDNA were used. They were as follows:
22-bp forward primer, CTSF (5 0 -TCG CAT CGA TGA AGA ACG CAG C-3 0 ), and 25-bp reverse primer, CTSR (5 0 -TCT TTT CCT CCG CTT ATT GAT ATG C-3 0 ).
DNA amplification and detection
A conventional PCR for the amplification of target DNA was carried out using PCR Beads in a total volume of 25 ml containing 5 ml of DNA template, 1 ml of each primer, and 18 ml of distilled water. PCR cycling was carried out in the thermal cycler (HYBAID-PCR Express) and was programmed for the following PCR steps: after 3 min of initial denaturation at 94 8C, the reaction mixture was run through 35 cycles of denaturation for 1 min at 94 8C, annealing for 30 s at 60 8C, and extension for 1 min at 72 8C. This was followed by a final extension for 10 min at 72 8C. 9 Finally, 10 ml of PCR product was mixed with 4 ml of 6Â loading buffer and electrophoresed on a 2% agarose gel for 20 min at 130 V, using 1Â Tris-borate-EDTA (TBE) buffer. The gel was stained with ethidium bromide (0.2 mg/l). After electrophoresis, amplicons were made visible by UV light. The size of the amplified DNA fragment (550 bp) was identified by comparison with molecular size marker DNA (100-bp DNA ladder).
Statistical analysis
The statistical analysis was performed using SPSS version 17.0 for Windows (SPSS Inc., Chicago, IL, USA). Continuous data were expressed as the mean AE standard deviation (SD) and compared using the Student's t-test. Categorical variables were expressed as the percentage and compared using the Chi-square test of Fisher's exact probability test. Multiple regression analysis was used to study the influence of independent variables on fungal infection. The level of significance was set at p < 0.05.
Results
Distribution of infections in the study patients
Forty-six patients with ESLD (28 males and 18 females) aged 45-72 years (mean age 56.7 AE 6.4 years) were included in this study. By microbial analysis of the ascitic fluid and blood samples of these patients with ESLD, 28 cases of infection were identified: 10 females and 18 males, with a mean age of 57.8 AE 6.1 years. Eighteen patients (eight females and 10 males) had no infection, and their mean age was 54.3 AE 6.8 years. The distribution of infections in the study patients is illustrated in Table 1 .
Diagnosis of fungal infection
Mycological culture assay indicated the growth of fungal species in five ascitic fluid samples and seven blood samples. These species were Candida (four in blood and three in ascitic fluid) and Aspergillus (four in blood and two in ascitic fluid). None of the patients had a C. neoformans infection. By PCR, 13 samples (six ascitic fluid and seven blood) were positive for fungal DNA (Tables  2 and 3) .
We found that 12 cases had a fungal infection (eight males and four females) and their mean age was 57.6 AE 8 years. Of these, seven cases (15.2%) had an isolated fungal infection: two of them had fungemia only (one by culture and one by culture and PCR), four had spontaneous fungal peritonitis only (two by culture and PCR and two by PCR), and one case had fungal isolation from ascitic fluid (by culture and PCR) as well as from blood (by culture and PCR) giving the diagnosis of disseminated fungal infection. The five remaining cases of fungal infection were combined with (or superimposed on) bacterial infections (two cases) and tuberculosis (three cases) ( Tables  2 and 3) .
The demographic characteristics, host factors, and microbiological data of these patients are shown in Table 3 .
Comparison between fungal and non-fungal infections
The demographic, clinical, and laboratory characteristics and underlying predisposing conditions of the study patients according to their microbial assessment are shown in Table 4 . There was no significant difference in age, gender, or clinical data between the fungal infection group and the other groups. Regarding underlying risk factors, a history of prophylactic antibiotics, MELD scores, and hepatorenal syndrome were significantly higher in patients with fungal infections compared to those with bacterial infections and those without infection. None of the patients had a history of corticosteroid use or immunosuppressive therapy. With regard to laboratory findings, patients with fungal infections had higher IL-17 levels than those in the other groups, but this was not statistically significant. No patient had neutropenia (an absolute neutrophil count <0.5 Â 109/l). Also, none of patients had evidence of CMV or HIV infection. In addition, patients with fungal infections had a higher mortality rate than those with non-fungal infections (p = 0.03).
Risk factor analysis for fungal infections
Multiple regression analysis was applied to determine the factors that independently predict the development of fungal infections, using variables that were significantly (p < 0.05) associated with fungal infection in the univariate analysis. A history of prophylactic antibiotics (for spontaneous bacterial peritonitis), hepatorenal syndrome, low ascitic fluid protein (<1 g/dl), and multiple risk factors (!3) were independent risk factors predicting fungal infection ( Table 5) .
Discussion
Our study sought to answer several questions on the frequency of IFI in ESLD, risk factors, and cellular immunity against it. Fungal infection is usually overlooked, with a delay in diagnosis, or passes without being noticed. This low index of suspicion might be due to a lack of signs of infection such as fever, or to the absence of the classic picture of peritonitis. Sometimes, clinical presentations of spontaneous fungal peritonitis are largely indistinguishable from those of spontaneous bacterial peritonitis. 10 In addition, the absence of characteristic ascitic fluid findings, as seen in our cases, Table 4 Comparison of demographic, clinical, and laboratory characteristics and associated risks among the study patients according to their microbial assessment a .
Isolated fungal infection (n = 7)
Bacterial infection (n = 16) where the ascitic fluid total protein is low (<1 g/dl), suggests a transudative rather than an exudative process. 11 Further factors contributing to fungal cultures not being performed routinely are the long period required for fungal growth and suboptimal microscopic evaluations and culture techniques. 10 Detecting fungal DNA by PCR in serum and ascitic fluid in our cases supported the diagnostic utility and enhanced the sensitivity for early detection of fungal infection. The relationship between immune dysfunction and infection in cirrhosis, known as cirrhosis-associated immune dysfunction syndrome (CAIDS), has been investigated extensively. 12 This syndrome is a multifactorial state of dysimmunoregulation, which is comprised of a reduction in serum bactericidal activity, opsonic activity, and complement and fibronectin levels. 12 Additional aspects of immunodeficiency are complicated by factors such as malnutrition, immunosuppressive medications, and alcohol intake. 13, 14 Patients with ESLD are more susceptible to infection, where impaired phagocytic function correlates with the severity of the liver disease, hyperammonemia, and hyponatremia. 15 Despite these qualitative and quantitative impairments in host immunity in ESLD, the risk of fungal infection is low. Our analysis identified IFI, i.e., the isolated type, in 15% of 46 patients with ESLD, where four cases had a spontaneous fungal infection, two cases had fungemia, and one had a disseminated infection. Our results are in agreement with those of previous studies, which have shown spontaneous fungal peritonitis associated with cirrhosis to be a rare process, as evidenced by the small number of cases reported in the literature. [16] [17] [18] Also, this low frequency of fungal infection in cirrhotic patients may be due to the lack of prolonged neutropenia and the presence of adequate numbers of functional neutrophils required for normal fungal host defense in the circulation. 19, 20 Chang et al. 19 noted that IFI is a well-known complication of prolonged neutropenia in patients with hematologic malignancies undergoing treatment. Moreover, the low frequency of fungal infection in patients with ESLD may be attributed to accelerated tissue injury leading to rapid death owing to activation of T cells during fungal tissue inflammation. 21 We determined the serum IL-17A (IL-17) level in cirrhotic patients to explain the cellular immune system response to fungal infection. IL-17 is one of the T cell-derived cytokines produced by pathogen-specific Th17 CD4 T cells, specifically memory CD4+ T cells. 22 IL-17 promotes antifungal immunity by inducing the release of a wide range of proinflammatory cytokines (tumor necrosis factor (TNF), IL-1, IL-6, granulocyte colony stimulating factor (G-CSF), and granulocyte-macrophage colony stimulating factor (GM-CSF)), the expansion of antimicrobial factors (S100 proteins), matrix metalloproteinases (MMP1, MMP3, and MMP13), and chemokine production (CXCL1, CXCL5, IL-8, CCL2, CCL7) at the site of infection, and the recruitment of neutrophils. 12, 23 We found that the IL-17 level was higher in our cirrhotic patients with fungal than other groups; this may play a part in the pathophysiology as a good immune system response against these infections resulting in their low frequency. Furthermore, Liang et al., 24 stated that, IL-17A may inhibit fungal growth by inducing beta-defensins and activating the acquired immune system.
Candida and Aspergillus species were the two most frequent pathogens in our patients. Spontaneous fungal peritonitis was mostly attributed to Candida species, while most of the fungemia was caused by Aspergillus species. Regarding Candida, translocation of supercolonized fungi secondary to changes in the bacterial flora from the alimentary tract, facilitated by upper gastrointestinal bleeding to the extraluminal areas, is the mechanism proposed for the development of spontaneous fungal peritonitis and subsequent further dissemination. 25 Unlike Candida, Aspergillus is usually acquired via the respiratory tract. 26 Moreover, direct percutaneous inoculation of fungi is the proposed route of ascitic fluid infection in those patients with intractable ascites who had a history of paracentesis.
We found no significant differences between patients with and without fungal infection as regards the clinical judgment, which is in agreement with the report by Saif and Raj. 10 In this study, increased ascitic fluid lymphocytes were seen among patients with fungal infections. This predominance may be a clue to non-bacterial causes, with consideration of a possible spontaneous fungal peritonitis. 18 Also, we showed three cases of spontaneous fungal peritonitis that had a clinical picture of spontaneous bacterial peritonitis but with neutrocytic negative bacterial culture ascites, supporting that this variant of spontaneous bacterial peritonitis is also a feature of fungal peritonitis. 27 The use of prophylactic antibiotics, low ascitic fluid protein (<1 g/dl), a higher MELD score, and hepatorenal syndrome were found to be independently associated with fungal infections in our study patients. Moreover, patients with multiple risk factors were more predisposed to such infections. It has been postulated that these prophylactic antibiotics suppress or change the normal intestinal flora leading to fungal overgrowth; these organisms then migrate across the intestinal wall to reach the peritoneal cavity and cause fungal peritonitis and dissemination. 28 Serum creatinine levels were significantly higher in patients with fungal infections compared to those without fungal infections. It is conceivable that renal failure (or hepatorenal syndrome) may merely be reflective of the overall complicated course and greater severity of illness, which may itself predispose these patients to fungal infections. 1 On the other hand, the association between renal failure and fungal infections is biologically probable where renal failure has been associated with defective cellmediated immunity and impaired granulocyte-macrophage function, which are the predominant host defenses against fungal pathogens. 29 We agree with Kim et al., who reported that higher MELD scores were significantly associated with bacterial or fungal infections, which may contribute to a worse clinical outcome. 30 In this study, no patient had a history of corticosteroid or immunosuppressive drug therapy. Unlike other studies, none of them had a CMV infection, which may have an impact on the risk of fungal infection. 31 This is why CMV should be investigated before transplantation.
In addition, we noticed that the in-hospital mortality was higher in patients with isolated fungal infections (28.6%). This is in agreement with the study of Stiefel et al., 32 who showed a higher mortality rate in cirrhotic patients who developed spontaneous fungal peritonitis. Advanced hepatic cirrhosis, disseminated fungal infection, and delayed diagnosis may contribute to these high mortality rates. Thus, there should be an increased awareness of fungal infection in patients with advanced cirrhosis, as delayed diagnosis and treatment may lead to serious consequences. 17, 18 Also, previous studies have shown the effects of pretransplantation fungal infections on the outcome after orthotopic liver transplantation (OLT). 30 Prompt OLT accompanied by adequate antifungal therapy may be acceptable in patients with a preexisting fungal infection unless there are overt manifestations of active infection. 30 The small number of patients in this series is one of the limitations of our study. Further studies with larger populations are needed on fungal infections, with special attention given to high-risk patients with ESLD.
In conclusion, the frequency of IFI in patients with ESLD was low; however, in patients with these infections, delayed diagnosis and treatment may contribute to high fatality rates. Hence, to improve the outcome in these patients, clinicians should have a high index of suspicion for this unusual but lethal entity so that it may be detected early, and empiric antifungal treatment should be started, especially in high-risk patients, until appropriate treatment can be used.
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